UnitedHealth Group Incorporated $UNH Shares Sold by Scholtz & Company LLC

Scholtz & Company LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,650 shares of the healthcare conglomerate’s stock after selling 3,151 shares during the quarter. UnitedHealth Group comprises approximately 2.3% of Scholtz & Company LLC’s holdings, making the stock its 17th biggest holding. Scholtz & Company LLC’s holdings in UnitedHealth Group were worth $5,194,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Brighton Jones LLC increased its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the period. O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the period. Private Trust Co. NA increased its stake in UnitedHealth Group by 5.9% during the 1st quarter. Private Trust Co. NA now owns 7,767 shares of the healthcare conglomerate’s stock worth $4,068,000 after buying an additional 436 shares during the period. Finally, Weaver Consulting Group increased its stake in UnitedHealth Group by 13.1% during the 1st quarter. Weaver Consulting Group now owns 508 shares of the healthcare conglomerate’s stock worth $266,000 after buying an additional 59 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $344.57 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a 50-day simple moving average of $342.82 and a 200 day simple moving average of $331.10. The company has a market cap of $312.07 billion, a PE ratio of 17.98, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the business posted $7.15 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on UNH. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.